Skip to main content
TipRanks
Go Ultimate75% OFF

Bukwang Pharmaceutical Co., Ltd. (003000) Stock Statistics & Valuation Metrics

Total Valuation

Bukwang Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 393.18B. The enterprise value is KRW 334.11B.

Market Cap
KRW 393.18B
Enterprise Value
KRW 334.11B

Share Statistics

Bukwang Pharmaceutical Co., Ltd. has 98,664,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
98,664,670
Owned by Insiders
―
Owned by Institutions
5.02%

Financial Efficiency

Bukwang Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.05%.

Return on Equity (ROE)
0.04
Return on Assets (ROA)
0.03
Return on Invested Capital (ROIC)
3.05%
Return on Capital Employed (ROCE)
0.04
Revenue Per Employee
308.79M
Profits Per Employee
19.34M
Employee Count
650
Asset Turnover
0.40
Inventory Turnover
2.01

Valuation Ratios

The current PE Ratio of Bukwang Pharmaceutical Co., Ltd. is 68.96. Bukwang Pharmaceutical Co., Ltd.’s PEG ratio is -1.23.

PE Ratio
68.96
PS Ratio
1.75
PB Ratio
1.20
Price to FCF
-88.36
Price to Operating Cash Flow
118.13
PEG Ratio
-1.23

Income Statement

In the last 12 months, Bukwang Pharmaceutical Co., Ltd. had revenue of 200.71B and earned 12.57B in profits. Earnings per share was 152.00.

Revenue
200.71B
Gross Profit
95.72B
Operating Income
14.16B
Pretax Income
6.39B
Net Income
12.57B
EBITDA
19.65B
Earnings Per Share (EPS)
152.00

Cash Flow

In the last 12 months, operating cash flow was 3.39B and capital expenditures -7.84B, giving a free cash flow of -4.45B billion.

Operating Cash Flow
3.39B
Free Cash Flow
-4.45B
Free Cash Flow per Share
-44.30

Dividends & Yields

Bukwang Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 3.14%

Dividend Per Share
―
Dividend Yield
3.14%
Payout Ratio
N/A
Free Cash Flow Yield
-1.13%
Earnings Yield
2.05%

Stock Price Statistics

Beta
0.04
52-Week Price Change
0.63%
50-Day Moving Average
3932.10
200-Day Moving Average
4943.32
Relative Strength Index (RSI)
55.08
Average Volume (3m)
412.90K

Important Dates

Bukwang Pharmaceutical Co., Ltd. upcoming earnings date is Mar 22, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 23, 2026
Next Earnings Date
Mar 22, 2027
Ex-Dividend Date
―

Financial Position

Bukwang Pharmaceutical Co., Ltd. as a current ratio of 2.59, with Debt / Equity ratio of 23.53%

Current Ratio
2.59
Quick Ratio
2.15
Debt to Market Cap
0.21
Net Debt to EBITDA
2.09
Interest Coverage Ratio
3.63

Taxes

In the past 12 months, Bukwang Pharmaceutical Co., Ltd. has paid -6.05B in taxes.

Income Tax
-6.05B
Effective Tax Rate
-0.95

Enterprise Valuation

Bukwang Pharmaceutical Co., Ltd. EV to EBITDA ratio is 22.38, with an EV/FCF ratio of -83.09.

EV to Sales
1.64
EV to EBITDA
22.38
EV to Free Cash Flow
-83.09
EV to Operating Cash Flow
109.13

Balance Sheet

Bukwang Pharmaceutical Co., Ltd. has KRW 169.10B in cash and marketable securities with KRW 80.67B in debt, giving a net cash position of KRW 88.43B billion.

Cash & Marketable Securities
KRW 169.10B
Total Debt
KRW 80.67B
Net Cash
KRW 88.43B
Net Cash Per Share
KRW 896.25
Tangible Book Value Per Share
KRW 3,356.03

Margins

Gross margin is 35.18%, with operating margin of 5.69%, and net profit margin of 3.65%.

Gross Margin
35.18%
Operating Margin
5.69%
Pretax Margin
3.98%
Net Profit Margin
3.65%
EBITDA Margin
7.33%
EBIT Margin
5.69%

Analyst Forecast

The average price target for Bukwang Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
22.17%
EPS Growth Forecast
-38.54%

Scores

Smart Score
―
AI Score
50